The objective of this renewal application is to continue work begun during the prior funding period focused on the analysis of the role of various candidate genes in hypertension through the manipulation of their dosage in genetically engineered mice. This prior work involved using gene targeting to create mice with zero, one, two, three, and four copies of candidate genes targeted at their normal chromosomal locations and then assessing the impact of these defined alterations on hypertension in the mouse. The studies demonstrated that gene dosage determines the levels of expression of these genes which either directly impacted on blood pressure, or had blunted effects on blood pressure due to homeostatic adjustments mediated by other genetic elements. The hypothesis that was developed from these prior studies and which is to be tested in the proposed studies are that variations in the level of expression of a variety of genes will lead to blood pressure changes that may be a reflection of increased expression of the manipulated genes or may be blunted or completely missed depending on the homeostatic adjustments mediated by other elements. Dr. Smithies interprets these blunted changes as virtual blood pressure changes since homeostatic adjustments (i.e.) altered chronic expression by other non-manipulated genes sensing blood pressure changes) which can be demonstrated result in an absence of detectable blood pressure changes. This hypothesis and its implications for the genetics of hypertension will be tested by the applicant in five specific aims. The first four aims will investigate the effects on blood pressure of altered expression of f our candidate genes: 1) the renin 1C gene 2) the Agtr1A gene 3) the type A natriuretic peptide receptor gene 4) the natriuretic peptide """"""""clearance"""""""" type receptor gene. The final specific aim involves the development of a path diagram displaying the interaction of these genetic determinants from Aims 1-4. This includes predictions and the testing of these predictions using crosses between the mice generated for these studies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL049277-08
Application #
6056251
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1992-09-30
Project End
2002-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
8
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Pathology
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Govindapillai, Arun; Hotchkiss, Adam; Baguma-Nibasheka, Mark et al. (2018) Characterizing the role of atrial natriuretic peptide signaling in the development of embryonic ventricular conduction system. Sci Rep 8:6939
Li, Feng; Kakoki, Masao; Smid, Marcela et al. (2018) Causative Effects of Genetically Determined High Maternal/Fetal Endothelin-1 on Preeclampsia-Like Conditions in Mice. Hypertension 71:894-903
Bai, Xue; Mangum, Kevin; Kakoki, Masao et al. (2017) GRAF3 serves as a blood volume-sensitive rheostat to control smooth muscle contractility and blood pressure. Small GTPases :1-10
Willett, Julian Ds; Lawrence, Marlon G; Wilder, Jennifer C et al. (2017) A tetraethylene glycol coat gives gold nanoparticles long in vivo half-lives with minimal increase in size. Int J Nanomedicine 12:2581-2592
Williams, Pete A; Harder, Jeffrey M; Foxworth, Nicole E et al. (2017) Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science 355:756-760
Lawrence, Marlon G; Altenburg, Michael K; Sanford, Ryan et al. (2017) Permeation of macromolecules into the renal glomerular basement membrane and capture by the tubules. Proc Natl Acad Sci U S A 114:2958-2963
Chang, Albert S; Grant, Ruriko; Tomita, Hirofumi et al. (2016) Prolactin alters blood pressure by modulating the activity of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 113:12538-12543
Chang, Albert S; Hathaway, Catherine K; Smithies, Oliver et al. (2016) Transforming growth factor-?1 and diabetic nephropathy. Am J Physiol Renal Physiol 310:F689-F696
Lawrence, Marlon; Testen, Anze; Koklic, Tilen et al. (2016) A Simple Method for the Size Controlled Synthesis of Stable Oligomeric Clusters of Gold Nanoparticles under Ambient Conditions. J Vis Exp :e53388
Hathaway, Catherine K; Chang, Albert S; Grant, Ruriko et al. (2016) High Elmo1 expression aggravates and low Elmo1 expression prevents diabetic nephropathy. Proc Natl Acad Sci U S A 113:2218-22

Showing the most recent 10 out of 123 publications